aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Hale's mission is to provide instant relief from nasal obstruction through its innovative product, Hale-Aid. This device mimics healthy nasal cartilage to improve airflow and is designed to be invisible, sitting inside the nostril. Hale-Aid addresses a common issue affecting 15% of the population, offering a discreet and effective solution.
Hale has made significant strides in the healthcare market with its unique approach to nasal relief. The company's impact is evident in its growing user base and positive feedback from customers who benefit from improved breathing and comfort.
Operating Status
Active
Ownership Type(s)
Bootstrapped
Main Product(s)
Medical Devices
Technology
HealthTech
Tags
eCommerce, Hardware
Model Types
Transactional
Customer Type(s)
Consumers
Geographic Exposure
United States
When was Hale founded?
Hale was founded in 2017.
Where is Hale’s headquarters located?
Hale’s headquarters is located in Baltimore, MD, US.
When was Hale’s last funding round?
Hale’s most recent funding round was for $675k (USD) in January 2020.
How many employees does Hale have?
Hale has 3 employees as of Feb 4, 2024.
How much has Hale raised to-date?
As of July 05, 2023, Hale has raised a total of $675k (USD) since Jan 27, 2020.
Add Comparison
Total Raised to Date
$675k
USD
Last Update Jan 27, 2020
Last Deal Details
$675k
USD
Jan 27, 2020
Seed
Total Employees Over Time
3
As of Feb 2024
Hale Address
3552 Roland Ave
Baltimore,
Maryland
21211
United States
TechCrunch
Revel to lay off 1,000 staff ride-hail drivers, saying they’d rather be contractors anyway
New York-based Revel has made a lot of pivots since initially launching in 2018 as a dockless e-moped sharing service. The BlackRock-backed...
Jun 6, 2024
Is this the right Hale?
Help us improve our AI - Is this article for the right company?
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts